Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 720-729

  Yule, Terecita D ^a   Roth, Mark B ^a   Dreier, Kimberly ^a   Johnson, Anthony F ^a   Palmer Densmore, Melissa ^a   Simmons, Kris ^a   Fanton, Robert ^a  

^a PFIZER INC   (United States)

Author keywords

acute phase proteins; canine parvovirus vaccine; CD4 neutrophil; leukopenia

Indexed keywords

ACUTE PHASE PROTEIN; CD4 ANTIGEN; CPV 2B; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DOG; INFLAMMATION; LEUKOCYTE; LYMPHOCYTOPENIA; NEUTROPENIA; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD4; APOLIPOPROTEINS; DOG DISEASES; DOGS; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; NEUTROPHILS; OROSOMUCOID; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; SERUM AMYLOID A PROTEIN; VIRAL VACCINES; VIRUS SHEDDING;

EID: 0030938648     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00232-0     Document Type: Article

References (39)

1. Parrish, C.R. Emmergence, natural history, and variation of canine mink, and feline parvoviruses. Adv. Virus Res. 1990, 38, 403-450
2. Parrish, C.R., Have, P., Foreyt, W.J. et al. The global spread and replacement of canine parvovirus strains. J. Gen. Virol. 1995, 69, 1111-1116
3. Parrish, C.R., O'Connell, P.H., Evermann, J.F. and Carmichael, L.E. Natural variation of canine parvovirus. Science 1985, 230, 1046-1048
4. Parrish, C.R., Aquadro, C.F., Strassheim, M.L. et al. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J. Virol. 1991, 65, 6544-6552
5. Carmichael, L.E. Canine parvovirus type-2 - an evolving pathogen of dogs. Ann. Med. Vet. 1994, 138, 459-464
6. Tattersall, P. Replication of the parvovirus MVM. 1. Dependence of virus multiplication and plaque formation on cell growth. J. Virol. 1972, 10, 586-590
7. Meunier, P.C., Cooper, B.J., Appel, M.J. and Slauson, D.O. Pathogenesis of canine parvovirus enteritis: the importance of viremia. Vet. Pathol. 1985, 22, 60-71
8. Meunier, P.C., Glickman, L.T., Appel, M.J. and Shin, S.J. Canine parvovirus in a commercial kennel: epidemiologic and pathologic findings. Cornell Vet. 1981, 71, 96-110
9. Pollock, R.V. and Carmichael, L.E. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J. Am. Vet. Med. Assoc. 1982, 180, 37-42
10. Carman, P.S. and Povey, R.C. Experimental challenge of dogs with canine parvovirus-2. Vet. Rec. 1980, 107, 447
11. Appel, MJ.G. and Carmichael, L.E. Can a commercial vaccine protect pups against a recent field isolate of parvovirus? Vet. Med. 1987, 82, 1091-1093
12. Woods, C.B., Pollock, R.V.H. and Carmichael, L.E. Canine parvoviral enteritis. J. Am. Anim. Hosp. Assoc. 1980, 16, 171-179
13. Owens, M.A. and Loken, M.R. Anonymous Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitative Immunophenotyping, Vol. 9 New Methods for Cell Enumeration. Wiley-Liss, New York, 1995, pp. 202-213
14. Mozes, G., Friedman, N. and Shainkin-Kestenbaum, R. Serum amyloid A: an extremely sensitive marker for intensity of tissue damage in trauma patients and indicator of acute response in various diseases. J. Trauma 1989, 29, 71-74
15. Baumann, H. and Gauldie, J. The acute phase response. Immunol. Today 1994, 15, 74-80
16. Beuscher, H.U., Fallon, R.J. and Colten, H.R. Macrophage membrane interleukin 1 regulates the expression of acute phase proteins in human hepatoma Hep 3B cells. J. Immunol. 1987, 139, 1896-1901
17. Shainkin-Kestenbaum, R., Berlyne, G., Zimlichman, S. et al. Acute phase protein, serum amyloid A, inhibits IL-1- and TNF-induced fever and hypothalamic PGE2 in mice. Scand. J. Immunol. 1991, 34, 179-183
18. Yamamoto, S., Miyaji, S., Ashida, Y. et al. Preparation of anti-canine serum amyloid A (SAA) serum and purification -of SAA from canine high-density lipoprotein. Vet. Immunol. Immunopathol. 1994, 41, 41-53
19. Ganapathi, M.K., Schultz, D., Mackiewicz, A. et al. Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells. J. Immunol. 1988, 141, 564-569
20. Schultz, D.R. and Arnold, P.I. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin. Arthritis Rheum. 1990, 20, 129-147
21. Johnson, A., Lauritzen, A., Sandbulte, J. et al. In vivo evaluation of canine parvovirus type 2b administered orally/intranasally to nine to ten week old specific-pathogen free beagle pups. [Abstract] CRWAD 1994, 78
22. Myers, L.E., McQuay, L.J. and Hollinger, F.B. Dilution assay statistics. J. Clin. Microbiol. 1994, 32, 732-739
23. Cobbold, S., Holmes, M. and Willett, B. The immunology of companion animals: reagents and therapeutic strategies with potential veterinary and human clinical applications. Immunol. Today 1994, 15, 347-353
24. Cobbold, S. and Metcalfe, S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 1994, 43, 137-154
25. Gebhard, D.H. and Carter, P.B. Identification of canine T-lymphocyte subsets with monoclonal antibodies. Vet. Immunol. Immunopathol. 1992, 33, 187-199
26. Cochran, W.G. and Cox, G.M. Experimental Designs. John Wiley and Sons, New York, 1950, p. 100
27. Hollander, M. and Wolfe, D. Nonparametric Statistical Methods. John Wiley and Sons, New York, 1973
28. Macartney, L., McCandlish, I.A., Thompson, H. and Cornwell, H.J. Canine parvovirus enteritis 1: Clinical, haematological and pathological features of experimental infection. Vet. Rec. 1984, 115, 201-210
29. Macartney, L., McCandlish, I.A., Thompson, H. and Cornwell, H.J. Canine parvovirus enteritis 2: pathogenesis. Vet. Rec. 1984, 115, 453-460
30. lck with CD4 in antigen-specific signal transduction in T cells. Cell 1991, 64, 511-520
31. Moore, P.F., Rossitto, P.V., Danilenko, D.M. et al. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 1992, 40, 75-85
32. Carman, P.S. and Povey, R.C. Pathogenesis of canine parvovirus-2 in dogs: haematology, serology and virus recovery. Res. Vet. Sci. 1985, 38, 134-140
33. Billiau, A., Heremans, H., Vandekerckhone, F. and Dillen, C. Anti-interferon gamma antibody protects mice against the generalized Shwartzman reaction. Eur. J. Immunol. 1987, 17, 1851-1854
34. Heremans, H., Van Damme, G., Dillen, C., Dijhmans, R. and Billiau, A. Interferon gamma, a mediator of lethal lipopolysaccharide-induced Schwartzman-like shock reactions in mice. J. Exp. Med. 1990, 171, 1853-1869
35. Cavender, D.E., Haskard, D.D., Joseph, B., Ziff, M. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J. Immunol. 1986, 136, 203-207
36. Bevilacqua, M.P., Pober, J.S., Wheeler, M.E. et al. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Invest. 1985, 76, 2003-2011
37. Issekutz, T.B. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. J. Immunol. 1990, 144, 2140-2146
38. Oppenheim, J.J., Zachariae, C.O., Mukaida, N. and Matsushima, K. Properties of the novel proinflammatory supergene "intercrine cytokine family". A. Rev. Immunol. 1991, 9, 617-648
39. Rice, J.B., Winters, K.A., Krakowka, S. and Olsen, R.G. Comparison of systemic and local immunity in dogs with canine parvovirus gastroenteritis. Infect. Immunol. 1982, 38, 1003-1009